Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

372 Press Releases
DateTitleCompany
08 Aug 17 Sanofi Files Suit in the U.S. to Defend its Patent Rights on Lantus® Sanofi,
Published by
GlobeNewswire
31 Jul 17 Sanofi: Online Availability of Sanofi Group's Half-Year Financial Report for 2017 Sanofi,
Published by
GlobeNewswire
31 Jul 17 Sanofi Raises FY 2017 Business EPS Guidance to Broadly Stable at CER Sanofi ,
Published by
PharmiWeb.com
21 Jul 17 Sanofi and Regeneron Receive Positive CHMP Opinion for Dupixent® (dupilumab) to Treat Adult Patients with Moderate-to-Severe Atopic Dermatitis Sanofi,
Published by
GlobeNewswire
21 Jul 17 Sanofi and Regeneron Receive Positive CHMP Opinion for Dupixent® (dupilumab) to Treat Adult Patients with Moderate-to-Severe Atopic Dermatitis Sanofi ,
Published by
PharmiWeb.com
12 Jul 17 Sanofi: Pre-quarterly Results Communication Sanofi,
Published by
GlobeNewswire
12 Jul 17 People with Multiple Sclerosis face delays in accessing treatments that could help slow down disability progression Sanofi Genzyme
11 Jul 17 Sanofi to acquire Protein Sciences Sanofi,
Published by
GlobeNewswire
15 Jun 17 Sanofi Launches "Action 2017", a Worldwide Employee Stock Purchase Plan Sanofi ,
Published by
PharmiWeb.com
15 Jun 17 Sanofi Launches "Action 2017", a Worldwide Employee Stock Purchase Plan Sanofi,
Published by
GlobeNewswire
14 Jun 17 Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlemen... Sanofi,
Published by
GlobeNewswire
10 Jun 17 In Senior Adults Treated with Basal Insulin, Switching to Sanofi's Toujeo® Halved Hypoglycemia Risk Sanofi,
Published by
PR Newswire
10 Jun 17 New Analysis Shows Sanofi's Soliqua® 100/33 Lowered HbA1c by More Than 2 Percent in Patients with Screening Levels Greater than 9 Percent Sanofi,
Published by
PR Newswire
31 May 17 Very Rare Disease Treatment Cerdelga® ? (eliglustat) To Be Made Available On The NHS, Reversing Previous Guidance Sanofi ,
Published by
PharmiWeb.com
31 May 17 Sanofi Genzyme Recognizes Ninth Annual World MS Day Sanofi Genzyme,
Published by
Business Wire
24 May 17 Sanofi and Regeneron Announce FDA Approval of Kevzara® (sarilumab) for the Treatment of Moderately to Severely Active Rheumatoid Arthritis in Adult Patients Sanofi ,
Published by
PharmiWeb.com
23 May 17 Sanofi and Regeneron Announce FDA Approval of Kevzara® (sarilumab) for the Treatment of Moderately to Severely Active Rheumatoid Arthritis in Adult Patients Sanofi ,
Published by
PharmiWeb.com
21 May 17 Sanofi Receives CHMP Recommendation for Approval of Insulin Lispro Biosimilar Sanofi ,
Published by
PharmiWeb.com
25 Apr 17 New Data Suggest Positive Effects of Sanofi Genzyme’s Aubagio® (teriflunomide) on Cortical Gray Matter Atrophy Sanofi Genzyme,
Published by
Business Wire
25 Apr 17 Sanofi Receives FDA Approval of Thymoglobulin® for the Prevention of Acute Kidney Transplant Rejection Sanofi ,
Published by
PharmiWeb.com
03 Apr 17 Sanofi Launches First-Ever ACT® Kids Toothpaste in the U.S. Sanofi,
Published by
PR Newswire
02 Apr 17 Switching to Sanofi's Toujeo® Showed Significant Reductions in Blood Sugar and Significantly Lower Incidence of Hypoglycemia in a Real-World Observational Study Sanofi,
Published by
PR Newswire
24 Apr 17 Sanofi and Regeneron Receive CHMP Positive Opinion for Kevzara® (sarilumab) to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis Sanofi,
Published by
GlobeNewswire
16 May 17 Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce... Sanofi,
Published by
GlobeNewswire
28 Apr 17 Sanofi and Regeneron Announce Kevzara® (sarilumab) Biologics License Application Resubmission Accepted for Review by US FDA Sanofi,
Published by
GlobeNewswire
05 Apr 17 Sanofi Appoints Bill Sibold Executive Vice President Sanofi Genzyme and Member of the Executive Committee Sanofi,
Published by
GlobeNewswire
30 Mar 17 Sanofi and Regeneron Announce FDA Approval of Dupixent® (dupilumab), the First Targeted Biologic Therapy for Adults with Moderate-to-Severe Atopic Dermatitis Sanofi ,
Published by
PharmiWeb.com
14 Apr 17 Sanofi: Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the... Sanofi,
Published by
GlobeNewswire
10 May 17 Sanofi: Annual General Shareholders' Meeting of May 10, 2017 Sanofi,
Published by
GlobeNewswire
19 May 17 Sanofi Receives CHMP Recommendation for Approval of Insulin Lispro Biosimilar Sanofi,
Published by
GlobeNewswire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.